For healthcare professionals only

Letters Why preclinical research has to evolve

Vaccine development might be handled more effectively in biotech companies than in academia

BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k758 (Published 21 February 2018) Cite this as: BMJ 2018;360:k758
  1. Juraj Ivanyi, professor (honorary) of immunology of infectious diseases
  1. Mucosal and Salivary Biology Division, Guy’s Campus of King’s College London, London SE1 1UL, UK
  1. juraj.ivanyi{at}kcl.ac.uk

Two Editorials in The BMJ comment on the implications of Cohen’s investigation into the handling of animal testing data and a clinical trial for the MVA85A tuberculosis vaccine. 123 Another aspect to consider is the current proportions at which medical research and development are distributed between UK …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription